Skip to main content
Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
14.18
-0.38 (-2.62%)
Dec 3, 2024, 1:16 PM EST - Market open

Axogen Revenue

Axogen had revenue of $48.64M in the quarter ending September 30, 2024, with 17.86% growth. This brings the company's revenue in the last twelve months to $180.86M, up 18.79% year-over-year. In the year 2023, Axogen had annual revenue of $159.01M with 14.74% growth.

Revenue (ttm)
$180.86M
Revenue Growth
+18.79%
P/S Ratio
3.50
Revenue / Employee
$422,558
Employees
428
Market Cap
623.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023159.01M20.43M14.74%
Dec 31, 2022138.58M11.23M8.81%
Dec 31, 2021127.36M15.06M13.41%
Dec 31, 2020112.30M5.59M5.24%
Dec 31, 2019106.71M22.78M27.13%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OrthoPediatrics 189.67M
EyePoint Pharmaceuticals 45.71M
Phathom Pharmaceuticals 26.27M
CorMedix 12.26M
IGM Biosciences 2.92M
Altimmune 52.00K
Revenue Rankings

AXGN News

More News